Polymer–drug conjugates (PDCs) have shown great promise in enhancing the efficacy and
safety of cancer therapy. These conjugates combine the advantageous properties of both …

Photodynamic therapy (PDT) is a promising cancer treatment which involves a
photosensitizer (PS), light at a specific wavelength for PS activation and oxygen, which …

Nanotheranostics have demonstrated the development of advanced platforms that can
diagnose brain cancer at early stages, initiate first-line therapy, monitor it, and if needed …

The chitosan-folate conjugate was synthesized initially and confirmed by FTIR and NMR
spectroscopic studies. Following, docetaxel (DXL) loaded non-targeted, single receptor and …

Upon extensive pharmaceutical and biomedical research to treat lung cancer indicates that
lung cancer remains one of the deadliest diseases and the leading cause of death in men …

Breast cancer, up-regulated with human epidermal growth factor receptor type-2 (HER-2)
has led to the concept of developing HER-2 targeted anticancer therapeutics. Docetaxel …

Lung cancer is the leading cause of cancer mortality worldwide. Owing to a lack of early-
stage diagnosis, most lung cancers are detected in advanced stages, limiting the available …

Brain cancer, up-regulated with transferrin receptor led to concept of transferrin receptor
targeted anticancer therapeutics. Docetaxel loaded d-α-tocopherol polyethylene glycol 1000 …

Docetaxel (DTX) is one of the important antitumor drugs, being used in several common
chemotherapies to control leading cancer types. Severe toxicities of the DTX are prominent …

Diagnosis and therapy of brain cancer was often limited due to low permeability of delivery
materials across the blood–brain barrier (BBB) and their poor penetration into the brain …